Q515--New 5 year BPA Heart and Kidney Biopsy Transplant Rejection Test Services and Reporting Per Statement of Work
Veterans Affairs · NETWORK CONTRACT OFFICE 19 (36C259)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25926Q0162 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Request for Quote (RFQ) #: 36C25926Q0162 New Five-Year Blanket Purchase Agreement Salt Lake City Heart and Kidney Transplant Rejection Test Services and Reporting Per Statement of Work This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with Revolutionary FAR Overhaul (RFO) Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The Government reserves the right to make no award from this solicitation. *The deadline for all questions is 16:00pm MT … (show all)
January 9, 2026. All questions must be submitted in writing no later than the question cut-off date marked above. All questions will be answered officially through an amendment to the solicitation. **Quotes are to be provided to Lindsey.Zwaagstra@va.gov no later than 16:00pm MT, January 23, 2026. Quotes shall not be hand carried. Faxed quotes shall not be accepted. Emailed quotes are the only method of submitted quotes (4MB email limit). The Government reserves the right to make the award solely on initial Quotes received. Offerors bear the burden of ensuring that all portions of the offer (and any authorized amendments) reach the designated office before the deadline specified in the solicitation. This RFQ shall be completed in its entirety, and signed and dated, failure shall not be considered for award. This is a Request for Quote (RFQ), and the solicitation number is 36C25926Q0162. The government anticipates awarding a firm-fixed price contract resulting from this solicitation. This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-06 effective October 01, 2025. The North American Industrial Classification System (NAICS) code for this procurement is 621511 Medical Laboratories with a business size standard of $41.5 Million. This solicitation is unrestricted. List of Line Items; Line Items Description Five Year Blanket Purchase Agreement Quantity Unit of Measure Unit Price ($) Total Price ($) 0001 Ordering Period 1 Heart and Kidney Transplant Rejection Testing and Reporting Salt Lake City VA Health Care System Period of Performance: 03/01/2026 02/28/2027 20 EA 0002 Ordering Period 2 Heart and Kidney Transplant Rejection Testing and Reporting Salt Lake City VA Health Care System Period of Performance: 03/01/2027 02/28/2028 20 EA 0003 Ordering Period 3 Heart and Kidney Transplant Rejection Testing and Reporting Salt Lake City VA Health Care System Period of Performance: 03/01/2028 02/28/2029 20 EA 0004 Ordering Period 4 Heart and Kidney Transplant Rejection Testing and Reporting Salt Lake City VA Health Care System Period of Performance: 03/01/2029 02/28/2030 20 EA 0005 Ordering Period 5 Heart and Kidney Transplant Rejection Testing and Reporting Salt Lake City VA Health Care System Period of Performance: 03/01/2030 02/28/2031 20 EA Grand Total ($) Description of Requirements for the items/Services to be acquired: The requirement is for heart and kidney transplant rejection test services and reporting, please reference attached statement of work (SOW). Delivery and acceptance are to be F.O.B Destination (RFO 52.247-34) at the VA Eastern Colorado Health Care System (ECHCS). Salt Lake City VA Medical Center 500 Foothill Drive Salt Lake City, UT, 84148 52.212-1, Instructions to Offerors-Commercial Items applies to this acquisition Any award made as a result of this solicitation will be made on an All or Nothing Basis. State if quoted items are available and priced through offerors existing Government-wide Acquisition Contract (GWAC), GSA Multiple Award Schedule (MAS) contract, or VA-wide Acquisition Contract. Offerors are warned against contacting any VA personnel other than the Contracting Officer and Contract Specialist prior to placement of any award made resulting from this RFQ. If such contact occurs and found to be prejudicial to competing contactors, the offeror making such contact may be excluded from award considerations. All proprietary information shall be clearly and properly marked. If the Offeror submits annexes, documentation, attachments or the like, not specifically required by this solicitation, such will count against the Offeror s page limitations unless otherwise indicated in the specific volume instructions below. All information shall be confined to the appropriate file. The offeror shall confine submissions to essential matters, sufficient to define the quote and provide an adequate basis for evaluation. Offerors are responsible for including sufficient details, in a concise manner, to permit a complete and accurate evaluation of each quote. ADDENDUM to RFO 52.212-1 INSTRUCTIONS TO OFFERORS COMMERCIAL Submission of quote shall include the following volumes: (I) Technical capability or quality offered to meet the Government requirement; (II) Price; and (III) Past Performance. Volume I - Technical capability or quality to meet the Government requirement. The offeror shall submit its quote demonstrating how it meets all of the requirements of the statement of work (SOW) and solicitation, to include verification of turnaround times required for specimens, verification testing will include T-cell mediated rejection (TCMR) and antibody mediated rejection (ABMR), and how reports will be provided to Salt Lake City VA Medical Center. Volume II Price Price - The offeror shall complete the pricing schedule provided in Section (v) above: Price/Cost Schedule. Volume III Past Performance Offerors shall provide a maximum of three (3) recent and relevant past efforts (as defined below) to demonstrate their ability to perform the proposed work. If a completed Contractor Performance Assessment Reporting System (CPARS) evaluation is available, it shall be submitted. If not providing CPARS evaluation past performance references must include contract numbers, amount of contract award, point of contact with email address, telephone numbers and other relevant information, and a description of product/work performed under the contract. To be relevant, the effort must be similar in nature of work, size, magnitude, complexity, and scope of this procurement. To be recent past performance is defined as not more than five years from the RFQ release date of this solicitation. Offeror must list any/all subcontractors (and their size standard IAW NAICS 621511) if they will be utilized for this requirement AND what they will be performing. (End of Addendum to 52.212-1) 52.212-2, Evaluation--Commercial Items applies to this acquisition. ADDENDUM to RFO 52.212-2 EVALUATION COMMERCIAL ITEMS: The Government will award a contract resulting from this solicitation to the offeror responsible whose offer conforming to the solicitation will be most advantageous to the Government considering price and other factors. The following factors shall be used to evaluate quotations: Factor I. Technical capability or quality offered to meet the Government requirements to include verification of turnaround times required for specimens, verification testing will include T-cell mediated rejection (TCMR) and antibody mediated rejection (ABMR), and how reports will be provided to Salt Lake City VA Medical Center. Factor II. Price Factor III. Past Performance Evaluation Approach. The Government will award a contract resulting from this solicitation to the responsible Offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The Government will use comparative analysis. The following factors will be used to evaluate offers: Factor I. Technical capability or quality offered to meet the Government requirement: The quotation will be evaluated to the extent to which it can meet and/or exceed the Government s requirements as outlined in the solicitation and based on the information requested in the instructions to quoters section of the solicitation.
Who won similar work
4 award notices on SAM.gov in the last 24 months. Matched by: Same office (NETWORK CONTRACT OFFICE 19 (36C259)), same NAICS 621511.
Single-winner award sizes (4): middle half $878K to $1.3M, median $1.1M; range $486K to $1.9M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| THE PATHOLOGY GROUP, P.C GRAND JUNCTION 81505 | 1 | $1.9M | Oct 3, 2025 |
| EXOSOME DIAGNOSTICS INC · $TECH · $1.2B | 1 | $1.1M | Sep 16, 2026 |
| CYTOPATH BIOPSY LAB INC | 1 | $1.0M | Sep 22, 2026 |
| VERACYTE LABS SD CORPORATION · $VCYT · $361.1M | 1 | $486K | May 29, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TECH reported $1.2B revenue in FY2026. The median single-winner award in these 4 past awards, $1.1M, is under 0.1% of that. 10-K
- $VCYT reported $361.1M revenue in FY2025. The median single-winner award in these 4 past awards, $1.1M, is 0.3% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Sep 22, 2026CYTOPATH BIOPSY LAB INC$1.0MQ301-- Molecular Thyroid TestingNo listed company matched (Materiality N/A)
- Sep 16, 2026EXOSOME DIAGNOSTICS INC$1.1MQ301--Base Year | 36C259-26-AP-1918 | Prostate Testing Non-Invasive | VISN ContractMateriality: 0.09% of $TECH revenue (Low) SEC
- May 29, 2026VERACYTE LABS SD CORPORATION$486KQ301--5 Year BPA Decipher Prostate TestMateriality: 0.09% of $VCYT revenue (Low) SEC
- Oct 3, 2025THE PATHOLOGY GROUP, P.C GRAND JUNCTION 81505$1.9MQ515--575 Anatomic Pathology Services per Statement of Work New 5 Year Blanket Purchase AgreementNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 2 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.